Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Exposure Prophylaxis”

Showing 20 of 0 results

Not applicableStudy completedNCT05350735
What this trial is testing

Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project

Who this might be right for
Rabies
Washington State University 180
Post-approval studies (Phase 4)Study completedNCT05853120
What this trial is testing

Doxy-Post-exposure Prophylaxis

Who this might be right for
Sexually Transmitted Diseases
Emory University 45
Not applicableNot Yet RecruitingNCT07268612
What this trial is testing

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

Who this might be right for
Anthrax
Emergent BioSolutions 250
Post-approval studies (Phase 4)Study completedNCT06433440
What this trial is testing

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

Who this might be right for
Rabies
University of Peshawar 100
Not applicableStudy completedNCT05684185
What this trial is testing

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Who this might be right for
Rabies Post-exposure Prophylaxis
Institut Pasteur du Cambodge 215
Testing effectiveness (Phase 2)Study completedNCT01729325
What this trial is testing

Prevention of Post-Traumatic Stress Disorder in Soldiers

Who this might be right for
Post-traumatic Stress Disorder (PTSD)Aggressive Behavior
University of Konstanz 118
Large-scale testing (Phase 3)Study completedNCT03877926
What this trial is testing

VELOCITY: An Anthrax Vaccine Clinical Study

Who this might be right for
Anthrax
Emergent BioSolutions 3,689
Testing effectiveness (Phase 2)Study completedNCT01753115
What this trial is testing

Ciprofloxacin BioThrax Co-Administration Study

Who this might be right for
Anthrax
Emergent BioSolutions 154
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Not applicableUnknownNCT02299583
What this trial is testing

Controlled Trial of Early Intervention With Children and Adolescents Exposed to Nonrelational Traumatic Events

Who this might be right for
Posttraumatic Stress DisorderDepressionAnxiety
Carolina Magdalene Maier 684
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584710
What this trial is testing

RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

Who this might be right for
Covid19
Restorbio Inc. 60
Not applicableNot Yet RecruitingNCT07561658
What this trial is testing

TelePharm PrEP/PEP

Who this might be right for
HIV
Fred Hutchinson Cancer Center 1,580
Not applicableLooking for participantsNCT05240924
What this trial is testing

ERP to Improve Functioning in Veterans With OCD

Who this might be right for
Obsessive Compulsive Disorder (OCD)Comorbid Post-Traumatic Stress Disorder and OCD
VA Office of Research and Development 160
Not applicableStudy completedNCT00000993
What this trial is testing

Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)WithdrawnNCT04435314
What this trial is testing

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19

Who this might be right for
covid19
Azidus Brasil
Large-scale testing (Phase 3)Study completedNCT03700242
What this trial is testing

Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year

Who this might be right for
Healthy Volunteers (Rabies Immunization)
Sanofi Pasteur, a Sanofi Company 570
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455318
What this trial is testing

Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.

Who this might be right for
Rabies (Healthy Volunteers)
Institute of Tropical Medicine, Belgium 561
Not applicableAvailableNCT05067166
What this trial is testing

Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Who this might be right for
Ebola Virus Disease
Ridgeback Biotherapeutics, LP
Testing effectiveness (Phase 2)Study completedNCT05639166
What this trial is testing

Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

Who this might be right for
COVID-19
Immune Biosolutions Inc 200
Not applicableStudy completedNCT05216588
What this trial is testing

Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

Who this might be right for
COVID-19Immunocompromised Host
ANRS, Emerging Infectious Diseases 149
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation